middle.news
How Algorae’s AI Platform Is Transforming Cancer Drug Discovery with Peter Mac
8:50am on Tuesday 29th of July, 2025 AEST
•
Healthcare
Read Story
How Algorae’s AI Platform Is Transforming Cancer Drug Discovery with Peter Mac
8:50am on Tuesday 29th of July, 2025 AEST
Key Points
Strategic partnership with Peter MacCallum Cancer Centre for preclinical validation
AI-driven drug synergy screening underway across four major cancer types
AlgoraeOS Version 2.0 development on track for Q3 2025 release
Progress in lead drug candidates AI-116 (dementia) and AI-168 (cardiovascular)
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Algorae Pharmaceuticals (ASX:1AI)
OPEN ARTICLE